| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,141 |
12,108 |
$555K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
580 |
551 |
$198K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,211 |
1,211 |
$107K |
| 99205 |
Prolong outpt/office vis |
345 |
345 |
$23K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
499 |
468 |
$21K |
| 20611 |
|
667 |
454 |
$20K |
| 76881 |
|
436 |
433 |
$15K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
51 |
50 |
$3K |
| 99215 |
Prolong outpt/office vis |
34 |
34 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
164 |
164 |
$2K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
28 |
15 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
64 |
64 |
$173.34 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
46 |
46 |
$138.01 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
84 |
79 |
$136.14 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14 |
13 |
$19.50 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
14 |
13 |
$4.03 |